In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality. Apixaban in patients at risk of stroke undergoing atrial. Apixaban is a safe alternative to warfarin during catheter. This booklet is for your information as you have been prescribed apixaban for the prevention of stroke in nonvalvular atrial fibrillation. Data were obtained on 48 442 patients with nonvalvular atrial fibrillation who had received an index prescription of dabigatran, rivaroxaban, or apixaban between october 19, 2010, through june 30, 2015, with final followup on october 1, 2015. If a patient is on dialysis and is above the age of 80 or weighs. Mar 24, 2019 using data from apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation aristotle n 18 201, a randomized trial comparing apixaban with warfarin in patients with af, we analyzed the subgroup of patients n 251 with prior valve surgery. The presence of atrial fibrillation af in this older patient population is high and increases the longterm risk for thrombotic events. Effectiveness and safety of apixaban versus rivaroxaban.
Treating atrial fibrillation in very old patients with new. Apixaban was associated with lower rates of allcause mortality and all stroke compared with a vitamin k antagonist in patients with atrial fibrillation. Patients were excluded if they had endstage kidney disease, cancer, a history of blood clots, or a history of hip or knee surgery. A retrospective registry study with data from the swedish patient register determined the swedish adult prevalence of af to be 2.
Treatment guidelines of atrial fibrillation afib or af. Continuous apixaban is safe and effective in patients undergoing atrial fibrillation ablation at risk of stroke with respect to bleeding, stroke, and. Compare apixaban and vitamink antagonists in patients. The doac group consisted mostly of patients treated with rivaroxaban 42% or dabigatran 33%, with only 192 and 84 patients treated with apixaban and edoxaban, respectively. Apixaban compared with warfarin in patients with atrial. The novel fxa inhibitor apixaban at a reduced dose of 2x 2. Xarelto is often used in patients undergoing knee or hip replacement surgery.
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation. Apixaban to prevent stroke in patients with atrial. Antithrombotic therapy after acute coronary syndrome or pci. The american heart association explains how to prevent a stroke, do you need aspirin or warfarin therapy for atrial fibrillation, c. Apixaban s package insert states that patients with atrial fibrillation may receive full dose apixaban 5 mg twice daily while on hemodialysis as long as they are under the age of 80 and weigh above 60 kg. To compare the safety and effectiveness of apixaban versus rivaroxaban for patients with nonvalvular atrial fibrillation. Medicines called antiarrhythmics can control atrial fibrillation. Efficacy and safety of apixaban vs warfarin in patients with. Atrial fibrillation af is the most common cardiac arrhythmia. Mar 09, 2020 in a retrospective cohort of 90,000 patients mean age, 69 with atrial fibrillation, investigators accessed 6 years of prescription data from a nationwide u. A phase iii study of apixaban in patients with atrial fibrillation full.
Jul 10, 2019 reduction of risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Atrial fibrillation and stroke prevention anticoagulants. Feb 10, 2011 in the study of about 5,600 patients with atrial fibrillation in which warfarin therapy was considered unsuitable, apixaban cut the risk of stroke by more than half compared with aspirin. Apixaban in patients with atrial fibrillation pubmed. In the seminal aristotle trial apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation, apixaban was associated with lower risks of stroke, bleeding, and death compared with warfarin. Apixaban compared against rivaroxaban for atrial fibrillation. Apixaban and rivaroxaban are the most commonly prescribed direct oral anticoagulants for adults with atrial fibrillation, but headtohead data comparing their safety and effectiveness are lacking. Full text apixaban in a morbid obese patient with atrial.
Vitamin k antagonists have been shown to prevent stroke in patients with atrial fibrillation. What is the efficacy and safety of apixaban eliquis use in. Apixaban versus acetylsalicylic acid asa to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin k. We compared the safety of apixaban with warfarin in 269 patients with atrial fibrillation and advanced chronic kidney disease defined as creatinine clearance crcl 25 to 30 mlmin enrolled in the aristotle trial apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation.
Atrial fibrillation af is the most common cardiac arrhythmia and is a major cause of ischemic stroke, heart failure and cardiovascular morbidity. What is the efficacy and safety of apixaban eliquis use. It may be read in its electronic format pdf or it may be printed and read. Association of oral anticoagulants and verapamil or diltiazem. Continuous apixaban therapy is a safe and effective alternative to vka in patients at risk of stroke undergoing atrial fibrillation ablation with respect to stroke, major bleeding, cognitive function, and mridetected acute brain lesions. The axafaafnet 5 trial was the first randomised trial to examine whether continuous apixaban was a safe alternative to a vka during catheter ablation of atrial fibrillation. Giugliano rp, ruff ct, braunwald e, et al, for the engage aftimi 48 investigators. Atrial fibrillation af is the most common cardiac arrhythmia which increases the risk of stroke and systemic embolism by 5 fold, it is a major. Factor xa inhibitors fibrinolytic agents pyrazoles pyridones apixaban aspirin. The area under the curve values for patients with crcl 25 to 30 mlmin fell within the ranges demonstrated for patients with crcl 30 mlmin. These 2,230 patients were wellmatched for the 10 baseline characteristics selected for use in the propensity score.
Apixaban versus warfarin in patients with atrial fibrillation. The perioperative management of patients who receive a direct oral anticoagulant doac for atrial fibrillation af and require elective surgery or procedure is a common clinical scenario for which best practices are uncertain. After propensity matching, the analysis cohort included 39,351 patients each with apixaban or rivaroxaban therapy. Between dec 19, 2006, and april 2, 2010, patients were enrolled in the aristotle trial at 1034 clinical sites in 39 countries. Introduction randomized clinical trials rcts and realworld data rwd in patients with atrial fibrillation have shown thatcompared to vitamin k antagonists vkasnonvka oral anticoagulants noacs are at least as effective in the prevention of ischaemic stroke, while decreasing the risk of bleeding. Furthermore, also due to the aging population, the number of patients. Apixaban eliquis is the third new oral anticoagulant recently labeled to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Comparison of dabigatran, rivaroxaban, and apixaban for. Apixaban in patients with esrd and atrial fibrillation. Perioperative management of patients with atrial fibrillation. An annual increase in apixaban prescriptions was observed following its marketing approval in the end of 2012.
Mar 16, 2020 mean followup was 288 apixaban or 291 rivaroxaban days. In a 2 x 2 factorial design, patients with atrial fibrillation undergoing coronary revascularization were randomized in a 1. Background nonvka oral anticoagulant agents have not been systematically used in patients with af after tavr. Atrial fibrillation is a supraventricular arrhythmia that adversely affects cardiac function and increases the risk of stroke. Jan 30, 2019 in summary, standarddose apixaban for the treatment of atrial fibrillation in patients with esrd may result in lower rates of major bleeding, stroke, and death compared with warfarin. Stroke prevention remains the mainstay of treatment for atrial fibrillation, and the recent advent. Outcomes associated with apixaban use in patients with end.
Patients with a chads 2 score of 1 consisted of 43% of the cohort, while patients with a chads 2 score of. During 12month followup, there was no significant difference in stroke rate. Direct oral anticoagulants for cancer patients with atrial. Effectiveness and safety of apixaban compared with rivaroxaban.
What are the treatment guidelines of atrial fibrillation afib. Direct comparisons of effectiveness and safety of treatment. Apixaban is a novel oral direct factor xa inhibitor that has been. Transient ischemic attacks in patients with atrial fibrillation. Patients over 18 years of age who were diagnosed with atrial fibrillation and received a new prescription for apixaban or rivaroxaban between 28 december 2012 and 1 january 2019. Apixaban in patients with atrial fibrillation after transfemoral aortic. Antithrombotic therapy after acute coronary syndrome or. Atrial fibrillation is a common arrhythmia that increases the risk of stroke. Methodsthe apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or. Additionally, the overall prevalence of af is increasing continuously, partly. Trials have compared the efficacy and safety of apixaban and rivaroxaban with warfarin in preventing stroke and systemic thromboembolism among patients with atrial fibrillation, but direct comparisons of these 2 treatments are currently lacking.
The recommended dose of eliquis for most patients is 5 mg taken orally twice daily. Effectiveness and safety of apixaban compared with. Background compared with the general population, patients with advanced chronic kidney disease have a 10fold higher. Patients taking the doacs rivaroxaban 2808, dabigatran 2189, and apixaban 1078 were matched by age, sex, and dates of enrollment and anticoagulant initiation with patients taking warfarin 10,021. In patients with atrial fibrillation for whom vitamin k antagonist therapy was unsuitable, apixaban reduced the risk of stroke or systemic embolism without significantly increasing the risk of. However, many patients are not suitable candidates for or are unwilling to receive vitamin k antagonist. Association of oral anticoagulants and verapamil or. Sep 20, 2019 nonvalvular atrial fibrillation patients. It is the most common arrhythmia and a major source of morbidity and. In patients with atrial fibrillation for whom vitamin k antagonist therapy was unsuitable, apixaban reduced the risk of stroke or systemic embolism without. Pdf apixaban in patients with atrial fibrillation researchgate. Objective we aim to evaluate the costeffectiveness of the noac apixaban versus other. If a patient is on dialysis and is above the age of 80 or weighs under 60 kg then the dose is reduced to 2. Patients with atrial fibrillation af who undergo cardioversion are at risk for thromboembolic events, and vitamin k antagonists appear to.
Efficacy and safety of apixaban compared with aspirin in the elderly. Vitamin k antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. The primary goal of this study is to assess the safety of two types of oral anticoagulants in patients with eskd on hemodialysis with nonvalvular atrial fibrillation nvaf. Efficacy and safety of apixaban vs warfarin in patients. Apixaban in a morbid obese patient with atrial fibrillation. The support for use of apixaban in these patients is largely based venous thromboembolism. In patients with atrial fibrillation for whom vitamin k antagonist therapy was unsuitable, apixaban reduced the risk of stroke or systemic.
Apr 15, 2014 apixaban eliquis is the third new oral anticoagulant recently labeled to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixabans package insert states that patients with atrial fibrillation may receive full dose apixaban 5 mg twice daily while on hemodialysis as long as they are under the age of 80 and weigh above 60 kg. Ng kh, shestakovska o, connolly sj, eikelboom jw, avezum a, diaz r, lanas f, yusuf s, hart rg. Doacs in patients with mitral stenosis and atrial fibrillation. Apixaban in patients with atrial fibrillation after. The present clinical case describes a practice experience about the use of plasmatic drug evaluation to assess the apixaban therapeutic levels in morbid obese patients with atrial fibrillation, and suggests the apixaban therapy could be as a valid alternative to vka therapy in this special population. A study of apixaban in patients with atrial fibrillation. Apixaban to prevent stroke in patients with atrial fibrillation. In the netherlands, the prevalence in the total population is 23% and in people of 75 years and older the prevalence of af increases to more than 10%. Atrial fibrillation is a common, costly and morbid cardiovascular arrhythmia. Methods we compared the safety of apixaban with warfarin in 269 patients with atrial fibrillation and advanced chronic. Eliquis apixaban and xarelto rivaroxaban are anticoagulants blood thinners used to reduce blood clotting and systemic embolism in patients with nonvalvular atrial fibrillation. Among patients with atrial fibrillation and crcl 25 to 30 mlmin, apixaban caused less bleeding than warfarin, with even greater reductions in bleeding than in patients with crcl 30 mlmin.
Information on atrial fibrillation patients on apixaban. Apixaban eliquis for stroke prevention in atrial fibrillation. Age 80 years or olderbody weight 60 kg or lessserum creatinine 1. Effectiveness and safety of apixaban versus rivaroxaban for. Effectiveness and safety of apixaban compared with rivaroxaban for patients with atrial fibrillation in routine practice. The us fda requires a risk evaluation and mitigation strategy rems for apixaban. Apixaban in patients with atrial fibrillation nejm.
296 817 676 841 585 902 1493 388 1013 1531 498 564 287 103 932 144 1508 815 134 220 1358 326 1141 1172 212 344 469 1581 835 773 113 348 556 1554 965 340 1358 1454 1480 142 998 1477 1493 296 657 167 412